SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001214659-22-013788
Filing Date
2022-11-15
Accepted
2022-11-15 16:30:13
Documents
2
Group Members
AULT ALPHA LPAULT LENDING, LLCAULT LIFE SCIENCES FUND, LLCAULT LIFE SCIENCES, INC.BITNILE HOLDINGS, INC.DAVID J. KATZOFFHENRY C.W. NISSERKENNETH S. CRAGUNWILLIAM B. HORNE

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 p1114220sc13da3.htm SC 13D/A 166726
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 50086
  Complete submission text file 0001214659-22-013788.txt   218445
Mailing Address 11411 SOUTHERN HIGHLANDS PARKWAY SUITE 240 LAS VEGAS NV 89141
Business Address
AULT MILTON C III (Filed by) CIK: 0001212502 (see all company filings)

State of Incorp.: DE
Type: SC 13D/A

Mailing Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326
Business Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Subject) CIK: 0001677077 (see all company filings)

IRS No.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: SC 13D/A | Act: 34 | File No.: 005-92615 | Film No.: 221391538
SIC: 2834 Pharmaceutical Preparations